Lung cancer antibody [Interpretation] in Serum or Plasma by Immunoassay   89041-8

LOINC Code


LOINC code89041-8
nameLung cancer antibody [Interpretation] in Serum or Plasma by Immunoassay
descriptionScreening for lung cancer using computerized tomography (CT) has been shown to decrease mortality by 20%. CT is an expensive procedure that also can reveal non-malignant changes on the chest CT. The EarlyCDT-Lung assay is a cheaper alternative with fairly good sensitivity and specificity for detecting early, asymptomatic non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). To achieve the desired specificity of 90%, the autoantibody cutoff values were chosen based on that goal. The overall sensitivity/specificity of the assay was determined to be 38%/88%. When the sensitivity and specificity were measured based on the type of tumor, NSCLC was 34%/88% and SCLC was 50%/88%.[http://cancerpreventionresearch.aacrjournals.org/content/4/7/1126.long#ref-1]
statusACTIVE

Fully-Specified Name

componentLung cancer antibody
propertyImp  =  Impression/interpretation of study
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
systemSer/Plas
    Ser  =  Serum
    Plas  =  Plasma
scaleNom  =  Nominal:  Nominal or categorical responses that do not have a natural ordering. (e.g., names of bacteria, reported as answers, categories of appearance that do not have a natural ordering, such as, yellow, clear, bloody.
methodIA  =  Immunoassay:  Encompasses all immunoassays with a few exceptions, including Immune Blot and Immune Fluorescence, which were created based on historic usage.

Additional Names

short nameLung cancer antibody SerPl IA-Imp

Basic Attributes

classSERO
type1  Laboratory
order vs. observationObservation

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

88863-6Lung cancer antibody panel - Serum or Plasma by Immunoassay

History/Usage

test rank16756 of 2000 most commonly performed tests by labs in USA
first released
last updated2.73
last change typeMIN  - change to field other than name

Related Names

Ab
EIA
ELFA
ELISA
Enzyme immunoassay
IAA
Impression
Impression/interpretation of study
Impressions
Interp
Interpretation
Lung cancer Ab
MEIA
Nominal
Pl
Plasma
Plsm
Point in time
Random
Serology
SerP
SerPl
SerPlas
Serum
Serum or plasma
SR
SUDS

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.